To continue reading this article, sign up for FREE to
Membership is FREE
and provides you with
instant access
to email newsletters, digital publications, our full content catalogue & more...
Already have an account?
nanoTherics Launches the magnefect-nano™ for Improved Gene Transfection
Read time: Less than a minute
nanoTherics has announced launch of the magnefect-nano™, a new device for improved gene transfection. The system uses a unique technique applying proprietary magnet configurations and oscillating array systems to promote particle/DNA uptake into cells thus significantly improving non-viral gene transfection whilst maintaining cell viability.
The system is designed by the company to provide improved transfection efficiency and effectiveness (up to 1000 x) over the best currently available cationic lipid agents at short transfection times.
Dr Linda Cammish, Chief Executive Officer, said, “We are delighted to be offering this new product to enable our customers to improve their transfection efficiencies with even the most hard to transfect cells”. She added, “We are committed to product development to meet our customers needs and aim to introduce a range of additional products throughout 2009. The in-vivo potential of this technology is particularly exciting, which is an area we will be placing particular focus on.”
The system is designed by the company to provide improved transfection efficiency and effectiveness (up to 1000 x) over the best currently available cationic lipid agents at short transfection times.
Dr Linda Cammish, Chief Executive Officer, said, “We are delighted to be offering this new product to enable our customers to improve their transfection efficiencies with even the most hard to transfect cells”. She added, “We are committed to product development to meet our customers needs and aim to introduce a range of additional products throughout 2009. The in-vivo potential of this technology is particularly exciting, which is an area we will be placing particular focus on.”